NuGen Medical Devices Inc., a leader in needle-free drug delivery, announced that its needle-free injection system and accessories, also known as InsuJet, has been approved by Health Canada specifically for the needle-free delivery of insulin.
While NuGen previously announced on December 9, 2021, that its needle-free injection system had received general use approval from Health Canada, the insulin specific approval is the first ever insulin specific needle-free system approved by Health Canada to sell into the healthcare system and its end users. Additionally, this approval may also aid in the process of obtaining coverage for the system by certain health care insurance providers in Canada.
